These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29200853)

  • 1. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
    Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
    Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive baicalin rhamno-nanocapsules as phytotherapeutic platform for treatment of acute myeloid leukemia.
    Heikal LA; El-Habashy SE; El-Kamel AH; Mehanna RA; Ashour AA
    Int J Pharm; 2024 Aug; 661():124458. PubMed ID: 38996823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Di-
    Briot T; Roger E; Bou Haidar N; Bejaud J; Lautram N; Guillet C; Thépot S; Legeay S; Lagarce F
    Int J Nanomedicine; 2019; 14():2091-2102. PubMed ID: 30988610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
    Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
    IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
    Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
    Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
    Roger E; Lagarce F; Benoit JP
    Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
    Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
    Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.
    Roger E; Lagarce F; Garcion E; Benoit JP
    Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
    Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
    ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
    Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
    Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decitabine for acute myeloid leukemia.
    Marks PW
    Expert Rev Anticancer Ther; 2012 Mar; 12(3):299-305. PubMed ID: 22369322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Cashen AF; Shah AK; Todt L; Fisher N; DiPersio J
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):759-66. PubMed ID: 17564707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A carrier-mediated prodrug approach to improve the oral absorption of antileukemic drug decitabine.
    Zhang Y; Sun J; Gao Y; Jin L; Xu Y; Lian H; Sun Y; Sun Y; Liu J; Fan R; Zhang T; He Z
    Mol Pharm; 2013 Aug; 10(8):3195-202. PubMed ID: 23822717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.
    Saliou B; Thomas O; Lautram N; Clavreul A; Hureaux J; Urban T; Benoit JP; Lagarce F
    Eur J Pharm Sci; 2013 Oct; 50(2):172-80. PubMed ID: 23831519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.
    Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C
    J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
    Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
    Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
    Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
    Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.
    Oellerich T; Schneider C; Thomas D; Knecht KM; Buzovetsky O; Kaderali L; Schliemann C; Bohnenberger H; Angenendt L; Hartmann W; Wardelmann E; Rothenburger T; Mohr S; Scheich S; Comoglio F; Wilke A; Ströbel P; Serve H; Michaelis M; Ferreirós N; Geisslinger G; Xiong Y; Keppler OT; Cinatl J
    Nat Commun; 2019 Aug; 10(1):3475. PubMed ID: 31375673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia.
    Park H; Chung H; Lee J; Jang J; Kim Y; Kim SJ; Kim JS; Min YH; Cheong JW
    Yonsei Med J; 2017 Jan; 58(1):35-42. PubMed ID: 27873493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.